Drugs / Tritanrix-HepB/Hib
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01175083 Background | Jun 2011 → Jan 2013 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tritanrix-HepB/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01175083 ↗ |
| Route | Intramuscular | “Intramuscular injection, 4 doses” NCT01175083 ↗ |